Korean J Dermatol.  2003 Oct;41(10):1381-1384.

A Case of Blastic NK-cell Lymphoma

Affiliations
  • 1Department of Dermatology, Seoul National University College of Medicine, Seoul, Korea. khcho@snu.ac.kr
  • 2Department of Pathology, Seoul National University College of Medicine, Seoul, Korea.
  • 3Department of Dermatology, Dankook University College of Medicine, Cheonan, Korea.

Abstract

A CD56+ lymphoma is a rare disease and has an aggressive behavior. Blastic NK-cell lymphoma has more aggressive characteristics and poorer prognosis than the other CD56+ lymphomas. Recently-revised WHO classification has included it as a new subcategory of primary cutaneous lymphoma. Herein we report a case of blastic NK-cell lymphoma occurred in 14 year-old Korean boy. We could differentiate it from other CD56+ lymphomas by clinical, pathological, and especially immunohistochemical findings: i.e. blastic NK-cell lymphoma is CD56+, CD3-, TdT+, EBER-. This case warrants further interest because of clear difference from Western reports in that it occurred at younger age.

Keyword

Blastic NK-cell lymphoma; CD56

MeSH Terms

Adolescent
Classification
Humans
Lymphoma*
Male
Prognosis
Rare Diseases
Full Text Links
  • KJD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr